| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-A71883111 |
| PharmacoGx | BRD-A71883111 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FUT9 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | STK17A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | VN1R1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | C11orf49 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | PIGK | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | TEKT5 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | MFAP3 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | PLS3 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | XPO4 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | PAGR1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
